X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83,296 | -3% | -$44,511 | ||||||
| A | 2024-02-26 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,007 | 81,726 | -4% | -$60,955 | |||||
| A | 2024-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,261 | -1% | -$9,223 | |||||
| A | 2024-03-01 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85,479 | -2% | -$28,195 | |||||
2024-03-05 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85,438 | -2% | -$28,195 | ||||||
2024-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,220 | -1% | -$9,223 | ||||||
2024-02-26 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,048 | 81,685 | -4% | -$61,786 | ||||||
2023-03-02 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $13.41 | -907 | 52,077 | -2% | -$12,165 | ||||||
2023-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $12.94 | -2,337 | 49,321 | -5% | -$30,236 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |